Acadian Asset Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$260K Buy
3,322
+1,883
+131% +$128K ﹤0.01% 1593
2026
Q1
$93K Sell
1,439
-2,398
-62% -$169K ﹤0.01% 1765
2025
Q4
$257K Sell
3,837
-20,013
-84% -$1.35M ﹤0.01% 1470
2025
Q3
$1.75M Buy
23,850
+22,678
+1,935% +$1.51M ﹤0.01% 925
2025
Q2
$60K Sell
1,172
-1,884
-62% -$107K ﹤0.01% 1458
2025
Q1
$195K Buy
+3,056
New +$178K ﹤0.01% 1261
2024
Q4
Sell
-7,612
Closed -$435K 1844
2024
Q3
$435K Buy
+7,612
New +$436K ﹤0.01% 1117
2023
Q2
Sell
-2,416
Closed -$92K 1802
2023
Q1
$92K Buy
+2,416
New +$113K ﹤0.01% 1410
2022
Q1
Sell
-3,057
Closed -$122K 1705
2021
Q4
$122K Buy
+3,057
New +$114K ﹤0.01% 1336
2021
Q1
Sell
-629
Closed -$27K 2172
2020
Q4
$27K Buy
+629
New +$22.6K ﹤0.01% 2090
2020
Q3
Sell
-1,302
Closed -$35K 2245
2020
Q2
$35K Sell
1,302
-4,163
-76% -$93.9K ﹤0.01% 2005
2020
Q1
$98K Sell
5,465
-23,431
-81% -$445K ﹤0.01% 1352
2019
Q4
$512K Buy
+28,896
New +$500K ﹤0.01% 1063
2019
Q3
Sell
-10,094
Closed -$173K 1923
2019
Q2
$173K Sell
10,094
-1,152
-10% -$18.6K ﹤0.01% 1259
2019
Q1
$181K Buy
+11,246
New +$182K ﹤0.01% 1377
2018
Q4
Sell
-43,469
Closed -$789K 1763
2018
Q3
$789K Sell
43,469
-42,592
-49% -$746K ﹤0.01% 786
2018
Q2
$1.45M Sell
86,061
-300,359
-78% -$5.68M 0.01% 648
2018
Q1
$7.57M Buy
+386,420
New +$7.48M 0.03% 345
2015
Q3
Sell
-205
Closed -$5K 1352
2015
Q2
$5K Buy
+205
New +$3.6K ﹤0.01% 1266

Other funds holding HALO

Acadian Asset Management's HALO Position: Q2 2026 in Review

Acadian Asset Management increased its Halozyme (HALO) stake by 131% in Q2 2026, buying an estimated $128K and bringing the position to 3,322 shares worth $260K. The position accounts for ﹤0.01% of the portfolio, ranked #1593.

Acadian Asset Management first reported a position in HALO in Q2 2015 and has held it in 19 quarters since. The position peaked at $7.57M in Q1 2018. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Acadian Asset Management held 3,322 shares of Halozyme worth $260K as of Q2 2026.
  • Acadian Asset Management bought 1,883 Halozyme shares in Q2 2026, an estimated $128K.
  • Halozyme made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1593 holding.
  • Acadian Asset Management first reported a position in Halozyme in Q2 2015 and has held it in 19 quarters since.
  • Acadian Asset Management's Halozyme position peaked at $7.57M in Q1 2018.
  • 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.